The debate about marijuana usage in transplant candidates: Recent medical evidence on marijuana health effects

Current Opinion in Organ Transplantation

Volumn 13, Issue 2, 2008, Pages 189-195

  Coffman, Kathy L ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE   (United States)

Author keywords

Medical marijuana; Motor skills; Psychosis; Tetrahydrocannabinoid; Transplantation

Indexed keywords

CANNABIS;

ABSTINENCE; BRAIN FUNCTION; CANCER RISK; CANNABIS ADDICTION; CELLULAR IMMUNITY; COGNITION; GRAFT RECIPIENT; HUMAN; INFECTION RISK; LABORATORY TEST; LAW; MOOD DISORDER; MOTOR PERFORMANCE; PHARMACOLOGY; PSYCHOSIS; REVIEW;

BRAIN; CANNABINOIDS; CANNABIS; HUMANS; MARIJUANA SMOKING; TRANSPLANTATION;

EID: 40649113186     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e3282f56139     Document Type: Review

References (64)

1. Substance Abuse and Mental Health Services Administration. Results from the 2002 National Survey on Drug Use and Health: National Findings, 1.1. Rockville, MD: NSDUH Office of Applied Studies; 2003. NHSDA Series H-22, DHHS Publ No SMA03-3836.
2. Hall W, Degenhardt L. Prevalence and correlates of cannabis use in developed and developing countries. Curr Opin Psychiatry 2007; 20:393-397.
3. Fowler CJ. Plant-derived, synthetic and endogenous cannabinoids as neuroprotective agents. Nonpsychoactive cannabinoids, "entourage" compounds and inhibitors of N-acyl ethanolamine breakdown as therapeutic strategies to avoid psychotropic effects. Brain Res Brain Res Rev 2003; 41:26-43.
4. Marzo VD, Bisogno T, DePetrocellis L. Endocannabinoids Part II: pathological CNS conditions involving the endocannabinoid system and their possible treatment with endocannabinoid-based drugs. Expert Opin Ther Targets 2001; 5:349-362.
5. Gobbi G, Bambico FR, Mangieri R, et al. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc Natl Acad Sci USA 2005; 102:18620-18625; Epub 2005 Dec 13.
6. Caspi A, Moffit Te, Cannon M, McClay J, et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environmental interaction. Biol Psychiatry 2005; 57:1117-1127.
7. Rawls SM, Gomez T, Raffa RB. An NMDA antagonist(LY 235959) attenuates abstinence-induced withdrawal of planarians following acute exposure to a cannabinoid agonist. Pharmacol Biochem Behav 2007; 86:499-504.
8. Seamon MJ, Fass JA, Maniscalco-Feichtl M, Abu-Schraie ND. Medical marijuana and the developing role of the pharmacist. Am J Health Syst Pharm 2007; 64:1037-1044.
9. Gorman DM, Charles Huber J Jr. Do medical cannabis laws encourage cannabis use? Int J Drug Policy 2007; 18:160-167; Epub Nov 15, 2006.
10. Kisely S. A tale of two jurisdictions. Can Australia and Canada learn from each other's experience with cannabis control? Aust N Z J Psychiatry 2005; 39:154-160.
11. Hall W. Reducing the harms caused by cannabis use: the policy debate in Australia. Drug Alcohol Depend 2001; 62:163-174.
12. Hall W. Cannabis use and the mental health of young people. Aust N Z J Psychiatry 2006; 40:105-113.
13. Fergusson DM, Horwood LJ. Early onset cannabis use and psychosocial adjustment in young adults. Addiction 1997; 92:279-296.
14. Lynsky MT, Heath AC, Bucholz KK, Slutske WS, et al. Escalation of drug use in early-onset cannabis users vs co-twin controls. JAMA 2003; 289:427-433.
15. Pope HG Jr, Gruber AJ, Hudson JI, Heustis MA, et al. Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry 2001; 58:909-915.
16. McDonald J, Schleifer L, Richards JB, deWit H. Effects of THC on behavioral measures of impulsivity in humans. Neuropsychopharmacology 2002; 28:1356-1365; Epub Apr 30, 2003.
17. Ramaekers JG, Kauert G, vanRuitenbeek P, Theunissen EL, et al. Highpotency marijuana impairs executive function and inhibitory motor control. Neuropsychopharmacology 2006; 31:2296-2303.
18. Ramaekers JG, Moeller MR, vanRuitenbeek P, Theunissen EL, et al. Cognition and motor control as a function of Delta 9- THC concentration in serum and oral fluid: limits of impairment. Drug Alcohol Depend 2006; 85:114-122; Epub May 24, 2006.
19. Khiabani HZ, Bramness JG, Bjorneboe A, Morland J. Relationship between THC concentration in blood and impairment in apprehended drivers. Traffic Inj Prev 2006; 7:111-116.
20. O'Kane CJ, Tutt DC, Bauer LA. Cannabis and driving: a new perspective. Emerg Med (Fremantle) 2002; 14:296-303.
21. Ramaekers JG, Berghaus G, van Laar M, Drummer OH. Dose related risk of motor vehicle crashes after cannabis. Drug Alcohol Depend 2004; 73:109-119.
22. Menetrey A, Augsburger M, Favrat B, Pin MA, et al. Assessment of driving capability through the use of clinical and psychomotor tests in relation to blood cannabinoids levels following oral administration of 20mg dronabinol or after a cannabis decoction made with 20 or 60mg Delta 9-THC. J Anal Toxicol 2005; 29:327-338.
23. Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007; 370:319-328. This paper is a nice review of the risks of depression and psychosis in cannabis use.
24. Semple DM, McIntosh AM, Lawrie SM. Cannabis as a risk factor for psychosis: a systematic review. J Psychopharmacol 2005; 19:187-194.
25. Roncero C, Collazos F, Valero S, Casas M. Cannabis consumption and development of psychosis: state of the art. Actas Esp Psiquiatr 2007; 35:182-189.
26. Fergusson DM, Horwood LJ, Ridder EM. Tests of causal linkages between cannabis use and psychotic symptoms. Addiction 2005; 100:354-366.
27. Medina KL, Nagel BJ, Park A, McQueeny T, et al. Depressive symptoms in adolescents: associations with white matter volume and marijuana use. J Child Psychol Psychiatry 2007; 48:592-600. In this paper an interesting linkage proposed between cannabis use and anatomic changes in the brain.
28. Kalant H. Adverse effects of cannabis on health: an update of the literature since. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28:849-863.
29. Williams CM, Kirkham TC. Anandamide induces overeating: mediation by central cannabinoid(CB1) receptors. Psychopharmacology (Berl) 1999; 143:315-317.
30. Ting JY. Reversible cardiomyopathy associated with acute inhaled marijuana use in a young adult. Clin Toxicol (Phila) 2007; 45:432-434. Interesting article on a rare reversible cause of organ failure.
31. Williams LJ, Correa A, Rasmussen S. Maternal lifestyle factors and risk for ventricular septal defects. Birth Defects Res A Clin Mol Teratol 2004; 70:59-64.
32. Aryana A, Williams MA. Marijuana as a trigger of cardiovascular events: speculation or scientific certainty? Int J Cardiol 2007; 118:141-144.
33. Daccaret M, Freih M, Machado C. Acute cannabis intoxication mimicking brugada-like ST segment abnormalities. Int J Cardiol 2007; 119:235-236. An arrhythmia to be aware of with the high prevalence of marijuana use.
34. Wallace D, Martin AL, Park B. Cannabinoid hyperemesis: marijuana puts patients in hot water. Austras Psychiatry 2007; 15:156-158. This paper describes that persisting vomiting is a common presenting symptom often labeled as psychological, but may have an underlying etiology that could easily be overlooked.
35. Pfeifer AK, Lange P. Pulmonary consequences of marijuana smoking. Ugeskr Laeger 2006; 168:1743-1746.
36. Aldington S, Williams M, Nowitz M, et al. The effects of cannabis on pulmonary structure, function and symptoms. Thorax 2007; 62:1058-1063. A useful review of the effects of cannabis of the lungs.
37. Heppner HJ, Sieber C, Schmitt K. "Usual" cannabis abuse producing an unusual incident. Dtsch Med Wochenschr 2007; 132:560-562.
38. Hashibe M, Ford DE, Zhang ZF. Marijuana smoking and head and neck cancer. J Clin Pharmacol 2002; 42 (11 Suppl):103S-107S.
39. Zhang X, Wang JF, Kunos G, Groopman JE. Cannabinoid Modulation of Kaposi's Sarcoma Associated herpesvirus infection and transformation. Cancer Res 2007; 67:7230-7237. The article shows that THC can alter HIV viral replication, no comment on effects on HCV.
40. Zhu LX, Sharma S, Stolina M, et al. Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway. J Immunol 2000; 165:373-380.
41. McKallip RJ, Nagarkatti M, Nagarkatti PS. Delta-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response. J Immunol 2005; 174:3281-3289.
42. Munckhof WJ, Konstantinos A, Wamsley M, Mortlock M, et al. A cluster of tuberculosis associated with use of a marijuana water pipe. Int J Tuberc Lung Dis 2003; 7:860-865.
43. Oeltmann JE, Oren E, Haddad MB, Lake L, et al. Tuberculosis outbreak in marijuana users, Seattle, Washington, 2004. Emerg Infect Dis 2006; 12:1156-1159.
44. Verweij PE, Kerremans JJ, Voss A, Meis JF. Fungal contamination of tobacco and marijuana. JAMA 2000; 284:2875.
45. Kagen SL, Kurup VP, Sohnle PG, Fink JN. Marijuana smoking and fungal sensitization. J Allergy Clin Immunol 1983; 71:389-393.
46. Klein TW, Newton CA, Nakachi H, Friedman H. Delta-9-tetrahydrocannabinol treatment suppressed immunity and early IFN-gamma,IL-12, and IL-12 receptor beta2 responses to Legionella pneumophila infection. J Immunol 2000; 164:6461-6466.
47. Johnson TE, Casiano RR, Kronish JW, Tse DT, et al. Sino-orbital aspergillosis in acquired immunodeficiency syndrome. Arch Ophthalmol 1999; 117:57-64.
48. Boggild AK, Putanen SM, Mohan S, Ostrowski Ma. Disseminated phaeohyphomycosis due to Ochroconis gallopavum in the setting of advanced HIV infection. Med Mycol 2006; 44:777-782.
49. Rocamora N, Tormo AM, Franco A, Alvarez Avellan L, et al. Fever and cavitary infiltrate in a renal transplant recipient. Nefrologia 2004; 24 (Suppl 3):16-20.
50. Marks WH, Florence L, Lieberman J, Chapman P, et al. Successfully treated invasive pulmonary aspergillosis associated with smoking marijuana in a renal transplant recipient. Transplantation 1996; 61:1771-1774.
51. Vethanayagam D, Pugsley S, Dunn EJ, Russell D, et al. Exogenous lipid pneumonia related to smoking weed oil following cadaveric renal transplantation. Can Respir J 2000; 7:338-342.
52. Soubani AI, Qureshi MA. Invasive pulmonary aspergillosis following bone marrow transplantation: risk factors and diagnostic aspect. Haemotologia (Budap) 2002; 32:427-437.
53. Hamadeh R, Ardehali A, Locksley RM, York MK. Fatal aspergillosis associated with smoking contaminated marijuana, in a bone marrow transplant recipient. Chest 1988; 94:432-433.
54. Heustis MA, Cone EJ. Differentiating new marijuana use from residual drug excretion in occasional marijuana users. J Anal Toxicol 1998; 22:445-454.
55. Cone EJ, Lange R, Darwin WD. In vivo adulteration: excess fluid ingestion causes false-negative marijuana and cocaine urine test results. J Anal Toxicol 1998; 22:460-473.
56. Schwartz RH, Willette RE, Hayden GF, Bogema S, et al. Urinary cannabinoids in monitoring abstinence in a drug abuse treatment program. Arch Pathol Lab Med 1987; 111:708-711.
57. Moyer TP, Palmen MA, Johnson P, Charlson JR, et al. Marijuana testing: how good is it? Mayo Clin Proc 1987; 62:413-417.
58. Leson G, Pless P, Grotenhermen F, Kalant H, et al. Evaluation the impact of hemp food consumption on workplace drug tests. J Anal Toxicol 2001; 25:691-698.
59. Steinagle GC, Upfal M. Concentration of marijuana metabolites in the urine after ingestion of hemp seed tea. J Occup Environ Med 1999; 41:510-513.
60. Tytgat J, Van Boven M, Daenens P. Cannabinoid mimics in chocolate utilized as an argument in court. Int J Legal Med 2000; 113:137-139.
61. Mule SJ, Lomax P, Gross SJ. Active and realistic passive marijuana exposure tested by three immunoassays and GC/MS in urine. J Anal Toxicol 1988; 12:113-116.
62. Hayden JW. Passive inhalation of marijuana smoke: a critical review. J Subst Abuse 1991; 3:85-90.
63. Niedbala RS, Kardos KW, Fritch DF, Kunsman KP, et al. Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle. J Anal Toxicol 2005; 29:607-615.
64. Paris M, Lenicque PM. Effect of tetrahydrocannabinol and of cannabidiol on wound healing and regeneration of the planaria Dugesia tigrina. Therapie 1975; 30:97-102.